| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5622429 | Alzheimer's & Dementia | 2017 | 10 Pages |
Abstract
An individual person's risk of progression from MCI to dementia can be improved by relying on CSF biomarkers in addition to recommended clinical and imaging tests for usual care.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Ron L.H. Handels, Stephanie J.B. Vos, Milica G. Kramberger, Vesna Jelic, Kaj Blennow, Mark van Buchem, Wiesje van der Flier, Yvonne Freund-Levi, Harald Hampel, Marcel Olde Rikkert, Ania Oleksik, Zvezdan Pirtosek, Philip Scheltens, Hilkka Soininen,